Plenary I: The Future of Healthcare Innovation

• A global perspective on science, regulation, and patient-centric transformation
• Senior leaders and regulators share their vision on how innovation, policy, and trust will define healthcare delivery in the next decade.

Plenary II: From Promise to Practice

• Translating science into scalable, sustainable healthcare solutions
• A cross-sector dialogue on execution-what it takes to move breakthrough ideas from labs to lives, at speed and with integrity.

Regulatory Science & Policy (RS)

• Regulatory convergence, reliance pathways, digital submissions, evolving Indian and global frameworks, and science-driven decision-making.

Advanced Therapy Medicinal Products (AT)

• Cell & gene therapies, RNA-based medicines, personalized treatments, and platform technologies, exploring development, regulation, manufacturing, and access pathways for next-generation therapies.

Clinical Development (CD)

• Advancing clinical and medical science and high-quality trial execution to deliver patient-centric evidence across the clinical development continuum, with India’s growing role in global clinical development.

Pharmacovigilance (PV)

• Next-generation safety systems, AI-enabled signal detection, risk management across products, and evolving global PV expectations.

Medical Affairs (MA)

• Strategic medical leadership, real-world evidence, scientific engagement, and the expanding role of Medical Affairs in value creation.

Data Science & Artificial Intelligence (DS)

• AI, advanced analytics, real-world data, interoperability, and governance—turning data into insight, trust, and better outcomes.

IAM 2026 is not just a conference; it is a strategic convergence point for those committed to advancing healthcare in India and globally.

If you are looking to anticipate change, influence policy, adopt innovation responsibly, and deliver better outcomes for patients, this is where the conversation and the future begin.